大森控股(01580.HK):柯明財等3人退任董事職務
格隆匯5月22日丨大森控股(01580.HK)發佈公告,誠如公司此前公佈,柯明財、 LIN Triomphe Zheng及邵萬雷將根據公司組織章程細則於股東周年大會上退任。由於重選該等董事的決議案於股東周年大會上未獲通過,柯明財、 LIN Triomphe Zheng及邵萬雷於股東周年大會結束時退任董事。
柯明財、 LIN Triomphe Zheng及邵萬雷退任董事後,柯明財亦退任董事會主席及公司提名委員會成員, LIN Triomphe Zheng亦退任公司審核委員會主席及成員,以及公司薪酬委員會及風險管理委員會成員,及邵萬雷亦退任公司提名委員會主席及成員,及公司審核委員會及薪酬委員會成員。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.